Henderson Jane sold APGE
September 3, 2026 · Form 4 insider transaction
Henderson Jane sold 158,371 shares of Apogee Therapeutics, Inc., a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
158,371
Price
N/A
Total value
N/A
InsiderHenderson Jane
RoleOfficer, Director
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateSeptember 3, 2026
Filing dateSeptember 3, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities represent shares of the Issuer's common stock disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of June 18, 2026 (the "Merger Agreement"), among Andor LLC, Andor Merger Co., the Issuer and AbbVie Inc.